The combined pharmacotherapy controversy.
Wakefield
T P
TP
D000342:Affective Symptoms / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D002648:Child; D002649:Child Abuse / Q000523:psychology; D002653:Child Behavior Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009769:Object Attachment; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics
D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D018967:Risperidone